Flow Cytometry Market

The global flow cytometry market size was valued at $4.7 billion in 2021, and is projected to reach $10.4 billion by 2031, growing at a CAGR of 8.3% from 2022 to 2031. Flow cytometry is a widely used method for analyzing the expression of cell surface and intracellular molecules, characterizing and defining different cell types in a heterogeneous cell population, analyzing cell size and volume and assessing the purity of isolated subpopulations. It allows simultaneous multi-parameter analysis of single cells. It is applied to measure fluorescence intensity produced by fluorescent-labeled antibodies detecting proteins and ligands that bind to specific cell-associated molecules like propidium iodide binding to DNA. The process involves the staining procedure followed by the incubation of the cells into the tubes or microtiter plates with unlabeled or fluorochrome-labeled antibodies and finally the analysis is done on the flow cytometer.

The COVID-19 pandemic had a positive impact on the flow cytometry market owing to the advantages, the flow cytometry technology has showed in research of COVID-19 like the ability to conduct immunophenotyping that allows the identification of SARS-CoV-2-specific immune responses.

The growth of the flow cytometry market size is driven by technological advancements and high adoption in various research and diagnostic applications. In addition, advent of flow cytometry technology in novel research applications such as cytogenomics, proteomics, and marine biology further supplement the flow cytometry market share.

Further, rise in incidences of diseases such as cancer and HIV are expected to boost flow cytometry market share. However, factors such as high-cost associated with instruments and reagents, lack of awareness among potential end users, and limited availability of technical expertise are expected to hamper the market growth. Preference of flow cytometry in drug discovery & development and diagnostics is expected to provide flow cytometry market opportunity.

Impact of COVID-19 Pandemic on Flow Cytometry Market

Amidst the initial outbreak of COVID-19, the outlook for the flow cytometry industry was positively impacted by the COVID-19 pandemic. The surge in use of reagents in research activities and clinical trials have increased the flow cytometry reagents market share thereby increasing the application of flow cytometry technology. For instance, Cytek Biosciences Inc. helped researchers and clinicians in the world to study impact of the COVID-19 virus on human immune systems in March 2020. Flow cytometry showed that COVID-19 patients reduced B-cell and T-cell frequencies compared to recovered donors and healthy donors. Moreover, according to the data by the National Institute of health (NIH), the flow cytometry analysis at the time of first evaluation after admission revealed significant differences among patients with moderate diseases with a severe phenotype and critical phenotype in U.S.

Segmental Overview

The flow cytometry market is segmented into Component, Technology, Application, End User and Region. By component, the flow cytometry market is segmented into instruments, reagents & consumables, software,  and services. The instrument segment is further divided into platforms, replaceable components, and accessories. The platforms segment is further categorized into sorters and analyzers. Filters, lasers, detectors, and others are considered as types of replaceable components. The reagents market is further divided into antibodies, dyes, beads, and others. On the basis of technology, the market is segmented into cell-based flow cytometry and bead-based flow cytometry. On the basis of application, it is segmented into academic & clinical applications and diagnostic applications. The academic & clinical applications segment is further divided into cell cycle analysis & cell proliferation, apoptosis, cell sorting, transfect ion & cell viability, and others. The diagnostic application segment is further segmented into organ transplantation, hematological malignancies, HIV, solid tumors & cancer, and others. On the basis of end user, the market is categorized into hospitals, medical schools & clinical testing labs, commercial organizations, academic institutions, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By Component

The instruments segment accounted for the highest market share in 2021, owing to development of novel instrument designs, demand for highly efficient replaceable components, applications in treatment of newer diseases, and increase in research & developments in flow cytometry techniques. Reagents & consumables are expected to emerge as the leading segment as they are essentials in flow cytometry analysis. The flow cytometry reagents market share is expected to grow owing to the combination of imaging capabilities and reagents usage for boosting the instrument performance and make it more accessible to emerging economies.

By Technology

The bead-based flow cytometry segment is expected to exhibit the fastest growth, registering a CAGR of 8.6% from 2022 to 2031, owing to its wide scale use in research applications, lesser time consumption, and simultaneous analysis of multiple samples. However, the cell-based flow cytometry segment is the highest revenue generating segment, owing to its wide scale application in the diagnosis of various diseases such as cancer and HIV, biomedical research, and its increasing use in monitoring the progress of drug treatment.

By Application

Academic & clinical applications segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to increase in research of academic & clinical applications  academic & clinical applications   of flow cytometry. However, the diagnostic applications segment is expected to exhibit a prominent growth rate, owing to rise in use of technology in diagnostic applications.

By End User

The commercial organizations segment accounted for a major share of the market share in the flow cytometry market in 2021, owing to heavy investments in R&D activities, advancements in cell- and bead-based technologies, growing patient population, and increasing demand for flow cytometry in drug discovery process. This segment is expected to exhibit a prominent growth rate of 9.0%, owing to increase in novel clinical applications and immunoassay processes, and diversified applications of flow cytometry in diseases diagnosis.

By Region

North America accounted for the highest revenue in the flow cytometry market in 2021. The flow cytometry market growth in the North America is supplemented by rapid technological advancements, increase in investments in research & development activities, rise in patent pool, and rise in the number of applications. However, Asia-Pacific flow cytometry industryis expected to emerge as the leading region, by registering a CAGR of 9.6% during the forecast period. This is mainly attributed to major international companies outsourcing their research processes to contract research organizations (CROs) located in Asia-Pacific. Moreover, impending need for sophisticated healthcare facilities and rise in incidences of chronic diseases such as HIV and cancer is expected to boost the growth of flow cytometry industry.

The major companies profiled in the report include Agilent Technologies, Inc. Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, DiaSorin S.p.A. (Luminex Corporation), Miltenyi Biotec, Inc., Sartorius AG, Sysmex Corporation, Thermo Fisher Scientific Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the flow cytometry market analysis from 2021 to 2031 to identify the prevailing flow cytometry market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the flow cytometry market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global flow cytometry market trends, key players, market segments, application areas, and market growth strategies.

 Flow Cytometry Market Report Highlights